Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Author David Tuttle to Host Book Signing for Soul Licensed at Frankfurter Buchmesse 2025
-
Judith A Perkins Signs Journey to the Pacific Series at Frankfurt Book Fair 2025
-
Imagen Network Integrates Grok Intelligence to Revolutionize Real-Time Personalization
-
Tocvan Advances Drilling, Trenching, and Pilot Mine Preparation, Mobilizing Equipment to North and South Blocks at Gran Pilar Gold-Silver Project
-
Aktsiaselts Infortar to start buy-back of up to 250,000 own shares
-
Further re pension contributions deferral
-
Transaction in Own Shares
-
Periodic announcement on the acquisition of the Bank‘s own shares and its results (week 2)
-
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
-
Iksuda Presents Encouraging IKS014 Phase 1 Data at ESMO
-
Lazard Appoints Edouard Panié as Managing Director and Co-Head of European Financial Sponsors Coverage
-
Lingokids Named to 2026 GSV 150: Recognized Among the World’s Most Transformational Growth Companies in Digital Learning & Workforce Skills
-
VAALCO Schedules Third Quarter 2025 Earnings Release and Conference Call
-
ST introduces new image sensors for industrial automation, security and retail applications
-
Accord Plasma B.V. Expands Global Plasma Therapy Capabilities with Acquisition of Prothya Biosolutions
-
Lingokids Named to 2026 GSV 150: Recognized Among the World’s Most Transformational Growth Companies in Digital Learning & Workforce Skills
-
NBPE - Transaction in Own Shares
-
OSB GROUP PLC - Transaction in Own Shares
-
Digital Identity Market to Exceed $80 Billion by 2030 Globally, Accelerated by Regulation & Hybrid Strategies
-
Holding(s) in Company
-
Genflow Biosciences PLC Announces Recognition of Patentability of Claims
-
FIFA 2026 Host City Monterrey Renews with SEVN as Exclusive Media Rights Partner for Legends Match on January 17, 2026
-
Digital Identity Market to Exceed $80 Billion by 2030 Globally, Accelerated by Regulation & Hybrid Strategies
-
China International College Students' Innovation Competition 2025 Finals Conclude in Zhengzhou
-
MILESEEY GenePro G1 Named to TIME's "The Best Inventions of 2025: Special Mentions"
-
TCM Group A/S: Major shareholder announcement
-
Chengdu CATANIA's Tower 2 Debuts Globally: A 222-Meter-High Sky Residence Redefining Global Luxury Living.
-
Chery Brand Night Grandly Opens - Co-Creating the “New Move” with Global Users
-
UAB “Orkela” concluded a EUR 40 million credit agreement with SEB Bank
-
A Ben Bacon to Host Exclusive Book Signing for The Coming at Frankfurt International Book Fair 2025
-
Author Wilma Cotten to Sign Memoir at Frankfurt Book Fair 2025
-
JASON CHRISTIAN WARNER, President of VBSZ: Advertising Pioneer and Passionate Philanthropist
-
Kelun-Biotech Presents Positive Phase 3 Data for Trastuzumab Botidotin Compared to T-DM1 at 2025 ESMO
-
Atlanta’s Dive Community Makes a Splash: PADI® Scuba Training and Certification Now Widely Available in the Region
-
Paratus Announces Receipt of Payment in Mexico
-
Abyan Capital Launches Shariah-Compliant, Self-Directed Access to US Markets with Alpaca
-
Sampo plc’s share buybacks 17 October 2025
-
Nextensa and Promobe sign long-term lease for new Terraces office building in Cloche d’Or district
-
From Service To Security: The Military Money Money Manual Teaches Service Members How to Achieve Financial Freedom
-
Zero-Barrier Passive Income: How Open Miner Cloud Mining Helps You Easily Unlock XRP and BTC Profits
-
Genentech’s Tecentriq Showed Significant Overall and Disease-Free Survival Benefits in Bladder Cancer With ctDNA-Guided Treatment
-
Successful IMvigor011 Trial Achieves 41% Improvement in Overall Survival for Bladder Cancer Patients
-
Roche’s Tecentriq showed significant overall and disease-free survival benefits in bladder cancer with ctDNA-guided treatment
-
TGS Awarded OBN 4D Contract in GoA
-
Comfone Launches 5G SA Roaming with BroadForward SEPP
-
Zeekr Group to Report Third Quarter 2025 Financial Results on November 17, 2025
-
FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis
-
A Scoop for Amsterdam: ARTIS Zoo officially recognized for protection of nocturnal darkness
-
Start of Day Message
-
Corbion reports the progress of its share buyback program 13 October – 17 October 2025
